ABOUT US         SERVICES         NOTABLE TRANSACTIONS         CONTACT  

Following is a selection of transactions which Rockport has represented.

	OTCBB: AXGN Biotech company commercializing products for peripheral nerve injury repair and regeneration. Reverse merger with LecTec Corporation: OTCBB LECT.
	Private Pharmaceutical company specializing in painless transdermal delivery of insulin Investor Syndicate: Aperture Venture Partners, Domain Associates, KBC Private Equity, Quilvest Ventures, Rockport Venture Fund, Venrock, vSpring Capital
	Private Medical device company developing interventional bronchoscopy devices for the treatment of emphysema Investor Syndicate: Abingworth Management, Boston Scientific, EDB Singapore,  HBM,  Pequot Ventures, Piper Jaffray,  Menlo Ventures,  Mitsui & Co.,   Oakwood Medical Management,  Pac-Link Management, Rockport Venture Fund
	Acquired by Varian Medical Systems Commercial stage medical device company with platform technology to actively track tumor position during radiation therapy Investor Syndicate: Apothecary Capital, Bay City Capital, BB Biotech Ventures, Frazier Healthcare Ventures, Glenview, Kaiser Permanente, Mitsui & Co., Pequot Ventures, RiverVest Venture Partners, Rockport Venture Fund, Utah Ventures, Versant Ventures
	Private Commercial stage medical device company with platform technology to accurately measure and wirelessly transmit vital cardiac information from inside the body Investor Syndicate: Arboretum Ventures, Aperture, Arcapita Ventures, Boston Millennia, Deerfield Management, Easton Capital, Foundation Medical, Guidant, J&J, Medtronic, Rockport Venture Fund, Vision Capital
	Private Developer of perfusion augmentation therapies for patients with cerebral ischemia resulting from stroke, vasospasm, and other conditions Investor Syndicate: Affinity Capital Management, Baird Venture Partners, Canaan Partners, Johnson & Johnson, Prism Venture Partners, Saints, Sofinnova Partners
	NASDAQ: CRXX Pharmaceutical company that discovers and develops novel synergistic combination medicines Investor Syndicate: Adams Street, BioVentures,  Canaan Partners, CDIB,  Flagship Ventures,  Foundation Medical, Global Life Science Ventures,  Novartis, POSCO BioVentures,  TL Ventures
	Private Commercial stage company marketing devices to enable novel transoral incisionless procedures to treat gastrointestinal diseases Investor Syndicate: Advanced Technology Ventures, Canaan Partners, Chicago Growth, DeNovo, Foundation Medical, MPM Capital, Oakwood Medical, Radius Ventures
	Acquired by C.R. Bard Commercial stage company marketing devices to facilitate the crossing of totally occluded coronary and peripheral arteries Investor Syndicate: AM Pappas, Frazier Healthcare Ventures, Gilde Healthcare, H&Q Capital, Life Sciences Partners, New Sciences Ventures,  Panorama Capital, Rockport Venture Fund
	Private Medical device company with breakthrough infusion pump platform technology for the hospital and home care markets Investor Syndicate: Cardinal Healthcare, CICA, Rockport Venture Fund, Univest
	AMEX: IGI IGI has developed topical delivery solutions based on its proprietary Novasome® lipid vesicle encapsulation technology PIPE Investor Syndicate: Signet Healthcare Partners
	Private One step, office-based, non-invasive diagnostic for Alzheimer's disease Investor Syndicate: Inventages
	NASDAQ: NSTR Northstar Neuroscience is pioneering the development of cortical stimulation therapies Investor Syndicate: AEA Investors, Boston Scientific, Canaan Partners, Domain Associates, Foundation Medical Partners, HBM Partners, J&J Development Corp, Mayfield Fund, SEB Asset Management
	Acquired by Septodont Commercial stage pharmaceutical company developing innovative therapies for the dental healthcare market Investor Syndicate: Boston Millennia Partners, Domain Associates, Genevest Consulting Group, Montreux Equity Partners, New Enterprise Associates, S.R. One
	Private Specialty pharmaceutical and medical device company offering a new approach to the management of postoperative pain Investor Syndicate: BB Biotech Ventures, Canaan Partners, ProQuest Investments, Rockport Venture Fund
	Private Medical device company with a portfolio of programmable implantable drug delivery devices Investor Syndicate: Arcus Ventures, Baird Ventures, BB Biotech Ventures, Cross Atlantic Partners, Fountain Healthcare Partners, Hambrecht & Quist, Nextech Ventures
	NASDAQ: SNTS Pharmaceutical company focused on the prevention & treatment of gastrointestinal diseases and disorders Investor Syndicate: Advent Venture Partners, CDIB, Domain Associates, Hamilton Apex, Life Science Partners, Panorama Capital, Split Rock, S.R. One, Windamere Venture Partners
	Acquired by Pfizer Pharmaceutical company developing best-in-class therapeutic and supportive care products for multiple clinical indications Investor Syndicate: InterSouth Partners, Lilly Ventures, Mediphase Venture Partners, Mitsubishi, Pac-Link Management, Ritchie Capital, Rockport Venture Fund, Takeda
	Private Commercial stage company with an implantable device to improve vision in individuals with end-stage age-related macular degeneration Investor Syndicate: Boston Scientific, BSI, Giza Ventures, Infinity, ONSET Ventures, Pitango, Saints Capital, Three Arch Partners
top of page

Rockport conducts all placements through its wholly owned subsidiary, Rockport Venture Securities, LLC.
Rockport Venture Securities is a member of FINRA, formerly the NASD, and SIPC.